Protein mutants that enhance the DNA cleavage activity of Acidaminococcus sp. CPF1
AssigneeIntegrated Dna Technologies, Inc.
InventorsLiyang Zhang, Christopher Anthony Vakulskas, Nicole Mary Bode, Michael Allen Collingwood, Kristin Renee Beltz, Mark Aaron Behlke
Life of this patent
Estimating the term…
Abstract
The present disclosure concerns polynucleotides and amino acids of Acidaminococcus sp. Cas12a (Cpf1) and methods for their use for genome editing in eukaryotic cells.
Claims13
A CRISPR-associated protein comprising a variant of a Cas12a, wherein the variant of the Cas12a comprises an amino acid sequence selected from the group consisting of SEQ ID NO:
- 472, 473 and 465.
A CRISPR ribonucleoprotein complex, comprising:
- a guide RNA;
- and
- a CRISPR-associated protein comprising a variant of a Cas12a, wherein the variant of the Cas12a comprises an amino acid sequence selected from the group consisting of SEQ ID NO:
- 472, 473 and 465.
A CRISPR-associated protein comprising a variant of the Cas12a—of SEQ ID NO.:
- 462, wherein the variant of the Cas12a comprises an amino acid sequence selected from the group consisting of SEQ ID NO:
- 59-245.
A Cas12a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:18-22 and 24-30.
A CRISPR-associated protein comprising a fusion polypeptide comprising a Cas12a protein, a nuclear localization signal, optionally an amino acid linker and optionally an affinity tag,
- wherein the Cas12a protein comprises an amino acid sequence selected from the group consisting of SEQ ID NO:
- 59-245, and
- wherein the nuclear localization signal comprises an amino acid sequence selected from SEQ ID NO:
- 475, 477, 479, 481 and 483.
A CRISPR-associated protein, wherein the CRISPR-associated protein is encoded by a nucleotide sequence selected from the group consisting of SEQ ID NO:
- 489 and 491.
A CRISPR-associated protein, wherein the CRISPR-associated protein comprises SEQ ID NO:
- 493.
Dependencies are inferred from the claim text.